Analystreport

Homology Medicines, Inc. (NASDAQ: FIXX) had its "buy" rating re-affirmed by analysts at Chardan Capital.

Homology Medicines, Inc.  (FIXX) 
Last homology medicines, inc. earnings: 3/12 04:10 pm Check Earnings Report